Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Goodwill & Intangibles (2021 - 2025)

Historic Goodwill & Intangibles for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $230000.0.

  • Pharmaceuticals' Goodwill & Intangibles fell 9998.31% to $230000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $230000.0, marking a year-over-year decrease of 9998.31%. This contributed to the annual value of $238000.0 for FY2024, which is 9998.71% down from last year.
  • Pharmaceuticals' Goodwill & Intangibles amounted to $230000.0 in Q2 2025, which was down 9998.31% from $233.0 million recorded in Q1 2025.
  • Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $1.8 billion for Q4 2023, and its period low was $230000.0 during Q2 2025.
  • For the 5-year period, Pharmaceuticals' Goodwill & Intangibles averaged around $442.9 million, with its median value being $16.0 million (2021).
  • Per our database at Business Quant, Pharmaceuticals' Goodwill & Intangibles skyrocketed by 17290094.07% in 2023 and then tumbled by 9998.71% in 2024.
  • Over the past 5 years, Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $16.0 million in 2021, then plummeted by 93.37% to $1.1 million in 2022, then skyrocketed by 172900.94% to $1.8 billion in 2023, then plummeted by 99.99% to $238000.0 in 2024, then fell by 3.36% to $230000.0 in 2025.
  • Its Goodwill & Intangibles stands at $230000.0 for Q2 2025, versus $233.0 million for Q1 2025 and $238000.0 for Q4 2024.